Totus Medicines Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 36

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $66M

  • Investors
  • 6

Totus Medicines General Information

Description

Developer of chemical biology technologies designed to create therapeutics for untreatable diseases. The company's technology uses the power of covalent bonding and a proprietary technology platform for high-throughput drug discovery, enabling pharmaceutical developers to convert genetic discoveries into real drugs to treat cancer, Alzheimer's, infectious diseases and even aging.

Contact Information

Formerly Known As
Trilogy Sciences
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1480 64th Street
  • Emeryville, CA 94608
  • United States
+1 (510)
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • 1480 64th Street
  • Emeryville, CA 94608
  • United States
+1 (510)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Totus Medicines Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series B) 15-Dec-2023 $66M Completed Pre-Clinical Trials
3. Early Stage VC (Series A2) 09-Dec-2021 Completed Pre-Clinical Trials
2. Seed Round 01-Jan-2020 $1000K $1000K Completed Startup
1. Accelerator/Incubator Completed Startup
To view Totus Medicines’s complete valuation and funding history, request access »

Totus Medicines Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-2
Series A-1
To view Totus Medicines’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Totus Medicines Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of chemical biology technologies designed to create therapeutics for untreatable diseases. The company's techn
Drug Discovery
Emeryville, CA
36 As of 2026

Houston, TX
 

Bala Cynwyd, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Totus Medicines Competitors (9)

One of Totus Medicines’s 9 competitors is GlycosBio, a Venture Capital-Backed company based in Houston, TX.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GlycosBio Venture Capital-Backed Houston, TX
Larimar Therapeutics Formerly VC-backed Bala Cynwyd, PA
Psygen Venture Capital-Backed Calgary, Canada
Conagen Corporate Backed or Acquired Bedford, MA
Definium Therapeutics Formerly VC-backed New York, NY
You’re viewing 5 of 9 competitors. Get the full list »

Totus Medicines Patents

Totus Medicines Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4784138-A1 Pharmaceutical compositions and methods of use thereof Pending 27-Sep-2023
WO-2025072796-A1 Pharmaceutical compositions and methods of use thereof Inactive 27-Sep-2023
WO-2024220380-A2 Pi3k assays and probe compounds therein Inactive 16-Apr-2023
WO-2024220380-A3 Pi3k assays and probe compounds therein Inactive 16-Apr-2023
EP-4604963-A2 Covalent inhibitors of wild-type and mutant pi3k and method of uses thereof Pending 18-Oct-2022 A61K31/5377
To view Totus Medicines’s complete patent history, request access »

Totus Medicines Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Totus Medicines Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Camford Capital Venture Capital Minority
DCVC Bio Venture Capital Minority
DHVC Venture Capital Minority
Northpond Ventures Venture Capital Minority
Social Impact Capital Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Totus Medicines FAQs

  • When was Totus Medicines founded?

    Totus Medicines was founded in 2019.

  • Where is Totus Medicines headquartered?

    Totus Medicines is headquartered in Emeryville, CA.

  • What is the size of Totus Medicines?

    Totus Medicines has 36 total employees.

  • What industry is Totus Medicines in?

    Totus Medicines’s primary industry is Drug Discovery.

  • Is Totus Medicines a private or public company?

    Totus Medicines is a Private company.

  • What is the current valuation of Totus Medicines?

    The current valuation of Totus Medicines is .

  • What is Totus Medicines’s current revenue?

    The current revenue for Totus Medicines is .

  • How much funding has Totus Medicines raised over time?

    Totus Medicines has raised $107M.

  • Who are Totus Medicines’s investors?

    Camford Capital, DCVC Bio, DHVC, Northpond Ventures, and Social Impact Capital are 5 of 6 investors who have invested in Totus Medicines.

  • Who are Totus Medicines’s competitors?

    GlycosBio, Larimar Therapeutics, Psygen, Conagen, and Definium Therapeutics are some of the 9 competitors of Totus Medicines.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process